Athersys: A Significantly Undervalued Stem Cell Company Approaching Key Catalysts

I suggest investors take a look at an under-followed company called Athersys (NASDAQ:ATHX). After decades of debate on the ethics of stem cell research, the rhetoric has ebbed and focus has shifted from ethics to the promises of clinical development. Companies all over the globe are now treading into the promising world of stem cells. Investors need to rethink this investment arena, and Athersys is one of the companies they should seriously consider.

While the bulls have long fantasized about huge profits from a miracle stem cell drug, the bears have consistently used facts about stem cell toxicities and their nascent state in the FDA drug development process to explain their reticence to jump onto stem cells' commercial...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
PRO Top long ideas returned 21.7% in 2016**
"As a PRO member, we get uniquely valuable perspective that go beyond our quantiative analysis... We rely on PRO to get beyond the numbers quickly and add much needed perspective. It keeps me ahead of the next big thing. - Mark Choate, Malaga Cove Capital"
Mark Choate, Malaga Cove Capital
"Contributors (writers and commentators), often have a long history in the secuirities they opine on and some are clearly well positioned industry participants with detailed industry views that can help provide color on where the skeletons are buried in a particular secuirity and/or industry."
Jim Roumell, Roumell Asset Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details